View ValuationSOL 将来の成長Future 基準チェック /36SOL利益と収益がそれぞれ年間11.5%と5.5%増加すると予測されています。EPS は年間 増加すると予想されています。自己資本利益率は 3 年後に14% 8.5%なると予測されています。主要情報11.5%収益成長率8.54%EPS成長率Chemicals 収益成長38.9%収益成長率5.5%将来の株主資本利益率13.99%アナリストカバレッジLow最終更新日15 May 2026今後の成長に関する最新情報更新なしすべての更新を表示Recent updatesUpcoming Dividend • May 11Upcoming dividend of €0.45 per shareEligible shareholders must have bought the stock before 18 May 2026. Payment date: 20 May 2026. Trailing yield: 0.8%. Lower than top quartile of British dividend payers (5.7%). Lower than average of industry peers (3.9%).Valuation Update With 7 Day Price Move • Apr 02Investor sentiment improves as stock rises 19%After last week's 19% share price gain to €59.13, the stock trades at a forward P/E ratio of 30x. Average forward P/E is 10x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 135% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €23.71 per share.Reported Earnings • Mar 30Full year 2025 earnings released: EPS: €1.84 (vs €1.63 in FY 2024)Full year 2025 results: EPS: €1.84 (up from €1.63 in FY 2024). Revenue: €1.81b (up 10% from FY 2024). Net income: €167.0m (up 13% from FY 2024). Profit margin: 9.2% (up from 9.0% in FY 2024). The increase in margin was driven by higher revenue. Revenue is forecast to grow 6.4% p.a. on average during the next 3 years, compared to a 10% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 5% per year but the company’s share price has increased by 30% per year, which means it is tracking significantly ahead of earnings growth.お知らせ • Mar 30SOL S.p.A., Annual General Meeting, May 12, 2026SOL S.p.A., Annual General Meeting, May 12, 2026, at 11:00 W. Europe Standard Time.Declared Dividend • Mar 29Dividend increased to €0.45Dividend of €0.45 is 15% higher than last year. Ex-date: 18th May 2026 Payment date: 20th May 2026 Dividend yield will be 0.8%, which is lower than the industry average of 3.0%. Payout Ratios Payout ratio: 23%. Cash payout ratio: 214%.お知らせ • Mar 27SOL S.p.A. announces Annual dividend, payable on May 20, 2026SOL S.p.A. announced Annual dividend of EUR 0.4500 per share payable on May 20, 2026, ex-date on May 18, 2026 and record date on May 19, 2026.New Risk • Sep 18New minor risk - Financial positionThe company has a high level of debt. Net debt to equity ratio: 49% This is considered a minor risk. Having a high level of debt increases the company's balance sheet risk. The company has a higher interest repayment burden, leading to the need to allocate a greater amount of its earnings towards servicing the debt, potentially limiting growth options or shareholder distributions. It can also increase the risk of bankruptcy if business conditions deteriorate enough that the company can no longer meet its debt obligations. This is currently the only risk that has been identified for the company.Reported Earnings • Sep 15First half 2025 earnings released: EPS: €0.92 (vs €0.83 in 1H 2024)First half 2025 results: EPS: €0.92 (up from €0.83 in 1H 2024). Revenue: €890.2m (up 13% from 1H 2024). Net income: €83.5m (up 12% from 1H 2024). Profit margin: 9.4% (in line with 1H 2024). Revenue is forecast to grow 4.9% p.a. on average during the next 3 years, compared to a 18% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 8% per year but the company’s share price has increased by 47% per year, which means it is tracking significantly ahead of earnings growth.Upcoming Dividend • May 12Upcoming dividend of €0.39 per shareEligible shareholders must have bought the stock before 19 May 2025. Payment date: 21 May 2025. Trailing yield: 0.9%. Lower than top quartile of British dividend payers (5.8%). Lower than average of industry peers (4.4%).Declared Dividend • Mar 31Dividend increased to €0.39Dividend of €0.39 is 5.4% higher than last year. Ex-date: 19th May 2025 Payment date: 21st May 2025 Dividend yield will be 1.0%, which is lower than the industry average of 3.0%.お知らせ • Mar 30SOL S.p.A. announces Annual dividend, payable on May 21, 2025SOL S.p.A. announced Annual dividend of EUR 0.3900 per share payable on May 21, 2025, ex-date on May 19, 2025 and record date on May 20, 2025.Reported Earnings • Mar 30Full year 2024 earnings released: EPS: €1.63 (vs €1.61 in FY 2023)Full year 2024 results: EPS: €1.63 (up from €1.61 in FY 2023). Revenue: €1.64b (up 9.3% from FY 2023). Net income: €147.7m (up 1.3% from FY 2023). Profit margin: 9.0% (in line with FY 2023). Revenue is forecast to grow 5.1% p.a. on average during the next 3 years, compared to a 4.1% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 14% per year but the company’s share price has increased by 30% per year, which means it is tracking significantly ahead of earnings growth.Reported Earnings • Sep 17First half 2024 earnings released: EPS: €0.83 (vs €0.88 in 1H 2023)First half 2024 results: EPS: €0.83 (down from €0.88 in 1H 2023). Revenue: €779.6m (up 3.0% from 1H 2023). Net income: €74.9m (down 5.9% from 1H 2023). Profit margin: 9.6% (in line with 1H 2023). Revenue is forecast to grow 7.4% p.a. on average during the next 3 years, compared to a 5.9% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 15% per year whereas the company’s share price has increased by 19% per year.Upcoming Dividend • May 13Upcoming dividend of €0.37 per shareEligible shareholders must have bought the stock before 20 May 2024. Payment date: 22 May 2024. Payout ratio is a comfortable 23% and this is well supported by cash flows. Trailing yield: 1.1%. Lower than top quartile of British dividend payers (5.7%). Lower than average of industry peers (2.8%).Reported Earnings • Mar 29Full year 2023 earnings released: EPS: €1.61 (vs €1.47 in FY 2022)Full year 2023 results: EPS: €1.61 (up from €1.47 in FY 2022). Revenue: €1.53b (up 5.4% from FY 2022). Net income: €145.7m (up 9.0% from FY 2022). Profit margin: 9.5% (in line with FY 2022). Revenue is forecast to grow 4.8% p.a. on average during the next 2 years, compared to a 4.6% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 15% per year but the company’s share price has increased by 28% per year, which means it is tracking significantly ahead of earnings growth.Reported Earnings • Sep 20Second quarter 2023 earnings released: EPS: €0.42 (vs €0.35 in 2Q 2022)Second quarter 2023 results: EPS: €0.42 (up from €0.35 in 2Q 2022). Revenue: €378.9m (up 11% from 2Q 2022). Net income: €38.5m (up 20% from 2Q 2022). Profit margin: 10% (in line with 2Q 2022). Revenue is forecast to grow 4.7% p.a. on average during the next 3 years, compared to a 6.7% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 19% per year but the company’s share price has increased by 33% per year, which means it is tracking significantly ahead of earnings growth.New Risk • Sep 17New minor risk - Financial positionThe company has a high level of debt. Net debt to equity ratio: 47% This is considered a minor risk. Having a high level of debt increases the company's balance sheet risk. The company has a higher interest repayment burden, leading to the need to allocate a greater amount of its earnings towards servicing the debt, potentially limiting growth options or shareholder distributions. It can also increase the risk of bankruptcy if business conditions deteriorate enough that the company can no longer meet its debt obligations. This is currently the only risk that has been identified for the company.Upcoming Dividend • May 15Upcoming dividend of €0.33 per share at 1.2% yieldEligible shareholders must have bought the stock before 22 May 2023. Payment date: 24 May 2023. Payout ratio is a comfortable 22% and this is well supported by cash flows. Trailing yield: 1.2%. Lower than top quartile of British dividend payers (5.9%). Lower than average of industry peers (2.3%).Board Change • Nov 16Less than half of directors are independentThere is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 11 experienced directors. No highly experienced directors. 5 independent directors (6 non-independent directors). Independent Director Erwin Paul Rauhe was the last independent director to join the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.Reported Earnings • Sep 18Second quarter 2022 earnings released: EPS: €0.35 (vs €0.26 in 2Q 2021)Second quarter 2022 results: EPS: €0.35 (up from €0.26 in 2Q 2021). Revenue: €357.9m (up 28% from 2Q 2021). Net income: €32.1m (up 36% from 2Q 2021). Profit margin: 9.0% (up from 8.5% in 2Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 26% per year but the company’s share price has only increased by 15% per year, which means it is significantly lagging earnings growth.Upcoming Dividend • May 09Upcoming dividend of €0.24 per shareEligible shareholders must have bought the stock before 16 May 2022. Payment date: 18 May 2022. Payout ratio is a comfortable 24% and this is well supported by cash flows. Trailing yield: 1.4%. Lower than top quartile of British dividend payers (4.8%). Lower than average of industry peers (2.7%).Board Change • Apr 27Less than half of directors are independentFollowing the recent departure of a director, there are only 5 independent directors on the board. The company's board is composed of: 5 independent directors. 6 non-independent directors. Independent Director Erwin Paul Rauhe was the last independent director to join the board, commencing their role in 2019. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Buying Opportunity • Mar 09Now 21% undervalued after recent price dropOver the last 90 days, the stock is down 21%. The fair value is estimated to be €20.15, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 8.3% per annum over the last 3 years. Earnings per share has grown by 34% per annum over the last 3 years.Reported Earnings • Sep 18Second quarter 2021 earnings released: EPS €0.26 (vs €0.23 in 2Q 2020)The company reported a solid second quarter result with improved earnings and revenues, although profit margins were weaker. Second quarter 2021 results: Revenue: €280.7m (up 17% from 2Q 2020). Net income: €23.7m (up 15% from 2Q 2020). Profit margin: 8.4% (down from 8.6% in 2Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 34% per year but the company’s share price has only increased by 22% per year, which means it is significantly lagging earnings growth.Board Change • Sep 15Less than half of directors are independentFollowing the recent departure of a director, there are only 5 independent directors on the board. The company's board is composed of: 5 independent directors. 6 non-independent directors. Independent Director Erwin Paul Rauhe was the last independent director to join the board, commencing their role in 2019. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Board Change • Jul 27Less than half of directors are independentFollowing the recent departure of a director, there are only 5 independent directors on the board. The company's board is composed of: 5 independent directors. 6 non-independent directors. Independent Director Erwin Paul Rauhe was the last independent director to join the board, commencing their role in 2019. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Reported Earnings • May 19Full year 2020 earnings released: EPS €1.19 (vs €0.58 in FY 2019)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: €987.1m (up 7.5% from FY 2019). Net income: €108.2m (up 107% from FY 2019). Profit margin: 11% (up from 5.7% in FY 2019). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 25% per year but the company’s share price has only increased by 16% per year, which means it is significantly lagging earnings growth.Upcoming Dividend • May 17Upcoming dividend of €0.22 per shareEligible shareholders must have bought the stock before 24 May 2021. Payment date: 26 May 2021. Trailing yield: 1.4%. Lower than top quartile of British dividend payers (4.1%). In line with average of industry peers (1.5%).Upcoming Dividend • May 10Upcoming dividend of €0.22 per shareEligible shareholders must have bought the stock before 17 May 2021. Payment date: 19 May 2021. Trailing yield: 1.3%. Lower than top quartile of British dividend payers (4.0%). Lower than average of industry peers (1.6%).業績と収益の成長予測LSE:0NJP - アナリストの将来予測と過去の財務データ ( )EUR Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数12/31/20282,201241130N/A312/31/20272,052217128412412/31/20261,916201102364412/31/20251,80416762296N/A9/30/20251,76916239272N/A6/30/20251,73515617248N/A3/31/20251,68715247273N/A12/31/20241,64014878297N/A9/30/20241,60114484297N/A6/30/20241,56314190297N/A3/31/20241,54414385283N/A12/31/20231,52514680270N/A9/30/20231,50514799276N/A6/30/20231,485149118281N/A3/31/20231,45514199246N/A12/31/20221,42513479210N/A9/30/20221,34611961192N/A6/30/20221,26610443173N/A3/31/20221,1999752183N/A12/31/20211,1329060193N/A9/30/20211,09410277207N/A6/30/20211,05611594221N/A3/31/20211,02210993216N/A12/31/202098710392210N/A9/30/202096683N/AN/AN/A6/30/20209456572182N/A3/31/20209325978184N/A12/31/20199195283186N/A9/30/201989949N/A170N/A6/30/201988049N/A154N/A3/31/201986351N/A144N/A12/31/201884552N/A133N/A9/30/201882852N/A138N/A6/30/201881051N/A144N/A3/31/201878946N/A140N/A12/31/201776840N/A137N/A9/30/201775241N/AN/AN/A6/30/201773642N/A122N/A3/31/201772643N/A120N/A12/31/201671544N/A118N/A9/30/201670840N/AN/AN/A6/30/201670235N/A122N/A3/31/201669534N/A107N/A12/31/201568932N/A93N/A9/30/201568331N/AN/AN/A6/30/201567730N/A100N/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: 0NJPの予測収益成長率 (年間11.5% ) は 貯蓄率 ( 3.4% ) を上回っています。収益対市場: 0NJPの収益 ( 11.5% ) はUK市場 ( 11.5% ) よりも速いペースで成長すると予測されています。高成長収益: 0NJPの収益は増加すると予測されていますが、大幅には増加しません。収益対市場: 0NJPの収益 ( 5.5% ) UK市場 ( 4.5% ) よりも速いペースで成長すると予測されています。高い収益成長: 0NJPの収益 ( 5.5% ) 20%よりも低い成長が予測されています。一株当たり利益成長率予想将来の株主資本利益率将来のROE: 0NJPの 自己資本利益率 は、3年後には低くなると予測されています ( 14 %)。成長企業の発掘7D1Y7D1Y7D1YMaterials 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/22 21:47終値2026/05/22 00:00収益2025/12/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋SOL S.p.A. 4 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。7 アナリスト機関Paola SagliettiBanca Akros S.p.A. (ESN)Davide ZappaBanca Akros S.p.A. (ESN)Catharina ClaesBerenberg4 その他のアナリストを表示
Upcoming Dividend • May 11Upcoming dividend of €0.45 per shareEligible shareholders must have bought the stock before 18 May 2026. Payment date: 20 May 2026. Trailing yield: 0.8%. Lower than top quartile of British dividend payers (5.7%). Lower than average of industry peers (3.9%).
Valuation Update With 7 Day Price Move • Apr 02Investor sentiment improves as stock rises 19%After last week's 19% share price gain to €59.13, the stock trades at a forward P/E ratio of 30x. Average forward P/E is 10x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 135% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €23.71 per share.
Reported Earnings • Mar 30Full year 2025 earnings released: EPS: €1.84 (vs €1.63 in FY 2024)Full year 2025 results: EPS: €1.84 (up from €1.63 in FY 2024). Revenue: €1.81b (up 10% from FY 2024). Net income: €167.0m (up 13% from FY 2024). Profit margin: 9.2% (up from 9.0% in FY 2024). The increase in margin was driven by higher revenue. Revenue is forecast to grow 6.4% p.a. on average during the next 3 years, compared to a 10% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 5% per year but the company’s share price has increased by 30% per year, which means it is tracking significantly ahead of earnings growth.
お知らせ • Mar 30SOL S.p.A., Annual General Meeting, May 12, 2026SOL S.p.A., Annual General Meeting, May 12, 2026, at 11:00 W. Europe Standard Time.
Declared Dividend • Mar 29Dividend increased to €0.45Dividend of €0.45 is 15% higher than last year. Ex-date: 18th May 2026 Payment date: 20th May 2026 Dividend yield will be 0.8%, which is lower than the industry average of 3.0%. Payout Ratios Payout ratio: 23%. Cash payout ratio: 214%.
お知らせ • Mar 27SOL S.p.A. announces Annual dividend, payable on May 20, 2026SOL S.p.A. announced Annual dividend of EUR 0.4500 per share payable on May 20, 2026, ex-date on May 18, 2026 and record date on May 19, 2026.
New Risk • Sep 18New minor risk - Financial positionThe company has a high level of debt. Net debt to equity ratio: 49% This is considered a minor risk. Having a high level of debt increases the company's balance sheet risk. The company has a higher interest repayment burden, leading to the need to allocate a greater amount of its earnings towards servicing the debt, potentially limiting growth options or shareholder distributions. It can also increase the risk of bankruptcy if business conditions deteriorate enough that the company can no longer meet its debt obligations. This is currently the only risk that has been identified for the company.
Reported Earnings • Sep 15First half 2025 earnings released: EPS: €0.92 (vs €0.83 in 1H 2024)First half 2025 results: EPS: €0.92 (up from €0.83 in 1H 2024). Revenue: €890.2m (up 13% from 1H 2024). Net income: €83.5m (up 12% from 1H 2024). Profit margin: 9.4% (in line with 1H 2024). Revenue is forecast to grow 4.9% p.a. on average during the next 3 years, compared to a 18% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 8% per year but the company’s share price has increased by 47% per year, which means it is tracking significantly ahead of earnings growth.
Upcoming Dividend • May 12Upcoming dividend of €0.39 per shareEligible shareholders must have bought the stock before 19 May 2025. Payment date: 21 May 2025. Trailing yield: 0.9%. Lower than top quartile of British dividend payers (5.8%). Lower than average of industry peers (4.4%).
Declared Dividend • Mar 31Dividend increased to €0.39Dividend of €0.39 is 5.4% higher than last year. Ex-date: 19th May 2025 Payment date: 21st May 2025 Dividend yield will be 1.0%, which is lower than the industry average of 3.0%.
お知らせ • Mar 30SOL S.p.A. announces Annual dividend, payable on May 21, 2025SOL S.p.A. announced Annual dividend of EUR 0.3900 per share payable on May 21, 2025, ex-date on May 19, 2025 and record date on May 20, 2025.
Reported Earnings • Mar 30Full year 2024 earnings released: EPS: €1.63 (vs €1.61 in FY 2023)Full year 2024 results: EPS: €1.63 (up from €1.61 in FY 2023). Revenue: €1.64b (up 9.3% from FY 2023). Net income: €147.7m (up 1.3% from FY 2023). Profit margin: 9.0% (in line with FY 2023). Revenue is forecast to grow 5.1% p.a. on average during the next 3 years, compared to a 4.1% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 14% per year but the company’s share price has increased by 30% per year, which means it is tracking significantly ahead of earnings growth.
Reported Earnings • Sep 17First half 2024 earnings released: EPS: €0.83 (vs €0.88 in 1H 2023)First half 2024 results: EPS: €0.83 (down from €0.88 in 1H 2023). Revenue: €779.6m (up 3.0% from 1H 2023). Net income: €74.9m (down 5.9% from 1H 2023). Profit margin: 9.6% (in line with 1H 2023). Revenue is forecast to grow 7.4% p.a. on average during the next 3 years, compared to a 5.9% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 15% per year whereas the company’s share price has increased by 19% per year.
Upcoming Dividend • May 13Upcoming dividend of €0.37 per shareEligible shareholders must have bought the stock before 20 May 2024. Payment date: 22 May 2024. Payout ratio is a comfortable 23% and this is well supported by cash flows. Trailing yield: 1.1%. Lower than top quartile of British dividend payers (5.7%). Lower than average of industry peers (2.8%).
Reported Earnings • Mar 29Full year 2023 earnings released: EPS: €1.61 (vs €1.47 in FY 2022)Full year 2023 results: EPS: €1.61 (up from €1.47 in FY 2022). Revenue: €1.53b (up 5.4% from FY 2022). Net income: €145.7m (up 9.0% from FY 2022). Profit margin: 9.5% (in line with FY 2022). Revenue is forecast to grow 4.8% p.a. on average during the next 2 years, compared to a 4.6% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 15% per year but the company’s share price has increased by 28% per year, which means it is tracking significantly ahead of earnings growth.
Reported Earnings • Sep 20Second quarter 2023 earnings released: EPS: €0.42 (vs €0.35 in 2Q 2022)Second quarter 2023 results: EPS: €0.42 (up from €0.35 in 2Q 2022). Revenue: €378.9m (up 11% from 2Q 2022). Net income: €38.5m (up 20% from 2Q 2022). Profit margin: 10% (in line with 2Q 2022). Revenue is forecast to grow 4.7% p.a. on average during the next 3 years, compared to a 6.7% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 19% per year but the company’s share price has increased by 33% per year, which means it is tracking significantly ahead of earnings growth.
New Risk • Sep 17New minor risk - Financial positionThe company has a high level of debt. Net debt to equity ratio: 47% This is considered a minor risk. Having a high level of debt increases the company's balance sheet risk. The company has a higher interest repayment burden, leading to the need to allocate a greater amount of its earnings towards servicing the debt, potentially limiting growth options or shareholder distributions. It can also increase the risk of bankruptcy if business conditions deteriorate enough that the company can no longer meet its debt obligations. This is currently the only risk that has been identified for the company.
Upcoming Dividend • May 15Upcoming dividend of €0.33 per share at 1.2% yieldEligible shareholders must have bought the stock before 22 May 2023. Payment date: 24 May 2023. Payout ratio is a comfortable 22% and this is well supported by cash flows. Trailing yield: 1.2%. Lower than top quartile of British dividend payers (5.9%). Lower than average of industry peers (2.3%).
Board Change • Nov 16Less than half of directors are independentThere is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 11 experienced directors. No highly experienced directors. 5 independent directors (6 non-independent directors). Independent Director Erwin Paul Rauhe was the last independent director to join the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
Reported Earnings • Sep 18Second quarter 2022 earnings released: EPS: €0.35 (vs €0.26 in 2Q 2021)Second quarter 2022 results: EPS: €0.35 (up from €0.26 in 2Q 2021). Revenue: €357.9m (up 28% from 2Q 2021). Net income: €32.1m (up 36% from 2Q 2021). Profit margin: 9.0% (up from 8.5% in 2Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 26% per year but the company’s share price has only increased by 15% per year, which means it is significantly lagging earnings growth.
Upcoming Dividend • May 09Upcoming dividend of €0.24 per shareEligible shareholders must have bought the stock before 16 May 2022. Payment date: 18 May 2022. Payout ratio is a comfortable 24% and this is well supported by cash flows. Trailing yield: 1.4%. Lower than top quartile of British dividend payers (4.8%). Lower than average of industry peers (2.7%).
Board Change • Apr 27Less than half of directors are independentFollowing the recent departure of a director, there are only 5 independent directors on the board. The company's board is composed of: 5 independent directors. 6 non-independent directors. Independent Director Erwin Paul Rauhe was the last independent director to join the board, commencing their role in 2019. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Buying Opportunity • Mar 09Now 21% undervalued after recent price dropOver the last 90 days, the stock is down 21%. The fair value is estimated to be €20.15, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 8.3% per annum over the last 3 years. Earnings per share has grown by 34% per annum over the last 3 years.
Reported Earnings • Sep 18Second quarter 2021 earnings released: EPS €0.26 (vs €0.23 in 2Q 2020)The company reported a solid second quarter result with improved earnings and revenues, although profit margins were weaker. Second quarter 2021 results: Revenue: €280.7m (up 17% from 2Q 2020). Net income: €23.7m (up 15% from 2Q 2020). Profit margin: 8.4% (down from 8.6% in 2Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 34% per year but the company’s share price has only increased by 22% per year, which means it is significantly lagging earnings growth.
Board Change • Sep 15Less than half of directors are independentFollowing the recent departure of a director, there are only 5 independent directors on the board. The company's board is composed of: 5 independent directors. 6 non-independent directors. Independent Director Erwin Paul Rauhe was the last independent director to join the board, commencing their role in 2019. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Board Change • Jul 27Less than half of directors are independentFollowing the recent departure of a director, there are only 5 independent directors on the board. The company's board is composed of: 5 independent directors. 6 non-independent directors. Independent Director Erwin Paul Rauhe was the last independent director to join the board, commencing their role in 2019. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Reported Earnings • May 19Full year 2020 earnings released: EPS €1.19 (vs €0.58 in FY 2019)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: €987.1m (up 7.5% from FY 2019). Net income: €108.2m (up 107% from FY 2019). Profit margin: 11% (up from 5.7% in FY 2019). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 25% per year but the company’s share price has only increased by 16% per year, which means it is significantly lagging earnings growth.
Upcoming Dividend • May 17Upcoming dividend of €0.22 per shareEligible shareholders must have bought the stock before 24 May 2021. Payment date: 26 May 2021. Trailing yield: 1.4%. Lower than top quartile of British dividend payers (4.1%). In line with average of industry peers (1.5%).
Upcoming Dividend • May 10Upcoming dividend of €0.22 per shareEligible shareholders must have bought the stock before 17 May 2021. Payment date: 19 May 2021. Trailing yield: 1.3%. Lower than top quartile of British dividend payers (4.0%). Lower than average of industry peers (1.6%).